CAPRIE Steering Committee; A randomised, blinded trial of Clopidogrel versus Aspirin in patients at risk of ischaemic events (CAPRIE). Lancet1996;348:1329-39.
2.
Bhatt DL, Bertrand ME, Berger PB et al. Meta-Analysis of Randomised and Registry Comparisons of Ticlopidine with Clopidogrel After Stenting; J Am Coll Cardiol2002;39:9-14.
3.
The Clopidogrel in Unstable angina to prevent Recurrent Events programme; Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. Eur Heart J2000;21:2033-41.
4.
Pursuit trial investigators; Inhibition of platelet glycoprotein IIB/IIIA with Eptifibatide in patients with Acute Coronary Syndromes. N Engl J Med1998;339:436-48.
5.
Simoons ML and the GUSTO IV-ACS Investigators; Effect of Glycoprotein IIB/IIIA receptor blocker Abciximab on outcome in patients with Acute Coronary Syndrome without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet2001 ;357:1915-24.
6.
Antithrombotic Trialists' Collaboration; Collaborative meta-analysis of randomised trials of anti-platelet therapy for prevention of death, myocardial infarction and stroke in high risk patients . BMJ2002;324:71-86.
7.
The Clopidogrel in Unstable angina to prevent Recurrent Events trial Investigators; Effects of pretreatment with clopidogrel and aspirin followed by long term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet2001;358:527-33.
